Susquehanna International Group, LLP Bridge Bio Pharma, Inc. Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 634,573 shares of BBIO stock, worth $34.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

634,573

Previous 739,704 14.21%

Holding current value

$34.9 Million

Previous $25.6 Million 7.15%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$30.14 - $45.12 $3.17 Million - $4.74 Million	-105,131 Reduced 14.21%	634,573 $27.4 Million
Q1 2025 May 14, 2025	SELL	$28.12 - $37.59 $13.6 Million - $18.2 Million	-484,578 Reduced 39.58%	739,704 $25.6 Million
Q4 2024 Feb 14, 2025	BUY	$22.35 - $29.5 $11.4 Million - $15 Million	509,125 Added 71.19%	1,224,282 $33.6 Million
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $920,726 - $1.21 Million	38,508 Added 5.69%	715,157 $18.2 Million
Q2 2024 Aug 15, 2024	BUY	$23.0 - $31.04 $14.2 Million - $19.2 Million	618,296 Added 1059.58%	676,649 $17.1 Million
Q1 2024 May 07, 2024	SELL	$27.35 - $40.45 $1.2 Million - $1.78 Million	-43,962 Reduced 42.97%	58,353 $1.8 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $7.33 Million - $13.4 Million	-305,338 Reduced 74.9%	102,315 $4.13 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $241,391 - $500,362	14,292 Added 3.63%	407,653 $10.7 Million
Q2 2023 Aug 11, 2023	SELL	$13.29 - $18.01 $1.75 Million - $2.38 Million	-131,947 Reduced 25.12%	393,361 $6.77 Million
Q1 2023 May 16, 2023	BUY	$7.17 - $18.55 $3.21 Million - $8.3 Million	447,691 Added 576.8%	525,308 $8.71 Million
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $1.22 Million - $2.08 Million	-180,426 Reduced 69.92%	77,617 $591,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $1.66 Million - $2.58 Million	208,650 Added 422.43%	258,043 $2.57 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $642,413 - $1.5 Million	-123,304 Reduced 71.4%	49,393 $448,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $1.71 Million - $4.01 Million	-233,634 Reduced 57.5%	172,697 $1.75 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $4.05 Million - $19 Million	355,718 Added 702.82%	406,331 $6.78 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $1.45 Million - $1.99 Million	30,957 Added 157.49%	50,613 $2.37 Million
Q2 2021 Aug 11, 2021	BUY	$46.47 - $63.93 $622,093 - $855,830	13,387 Added 213.54%	19,656 $1.2 Million
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $653,436 - $852,282	-11,780 Reduced 65.27%	6,269 $386,000
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $86,546 - $160,353	-2,255 Reduced 11.11%	18,049 $1.28 Million
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $216,811 - $336,296	-7,971 Reduced 28.19%	20,304 $761,000
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $376,184 - $604,231	-16,930 Reduced 37.45%	28,275 $922,000
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $728,252 - $1.64 Million	45,205 New	45,205 $1.31 Million
Q4 2019 Feb 14, 2020	SELL	$17.96 - $46.63 $181,000 - $469,937	-10,078 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $202,870 - $326,325	10,078 New	10,078 $216,000

Others Institutions Holding BBIO

# of Institutions

410

Shares Held

187M

Call Options Held

11.3M

Put Options Held

1.91M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $8.16B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Bridge Bio Pharma, Inc. Transaction History